A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2006
12/12/2006	US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors
12/12/2006	US7148329 For modulating, in particular increasing or reducing, the immune response in an animal, such as a human or another mammal
12/12/2006	US7148326 Tumor antigen
12/12/2006	US7148323 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
12/12/2006	US7148201 Use of human plasma hyaluronidase in cancer treatment
12/12/2006	US7148191 Antigenic composition
12/12/2006	US7148050 method of screening for agents which decrease extracellular matrix degradation; test compound which binds to the proteine kinase-like protein polypeptide is thereby identified as a potential agent for decreasing extracellular matrix degradation
12/12/2006	US7148038 Immunotherapy; antiproliferative agent
12/12/2006	US7148037 Platelet-derived growth factor D, DNA coding therefor, and uses thereof
12/12/2006	US7148035 Polypeptide
12/12/2006	US7148028 For diagnosis, prognosis, prophylaxis
12/12/2006	US7148019 Treating grass pollen allergen by administering a genetic engineered or synthetic protein or polypeptide; antiallergens
12/12/2006	US7148015 Circovirus sequences associated with piglet weight loss disease (PWD)
12/12/2006	US7147862 Vaccines containing QS21, an Hplc purified non-toxic fraction derived from the bark of Quillaja Saponaria Molina, and 3 De-O-acylated monophosphoryl lipid A (3 D-MPL); combinations of QS21 and 3 D-MPL synergistically enhance immune responses to a given antigen
12/12/2006	US7147861 Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate
12/12/2006	US7147859 Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
12/12/2006	US7147858 Methods to improve immunogenicity of antigens and specificity of antibodies
12/12/2006	US7147857 Methods for treating high somatic cell counts
12/12/2006	US7147856 Stable radioiodine conjugates and methods of their synthesis
12/12/2006	US7147855 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
12/12/2006	US7147854 Administering a monoclonal antibody which is a murine anti-human IL-8 monoclonal antibody, for treating skin inflammatory diseases
12/12/2006	US7147853 Nucleotide sequences codin polypeptide for use in the treatment and prevention of cell proliferative and tumor disorders
12/12/2006	US7147852 Methods for reducing TGF-β production and for promoting repair of liver damage
12/12/2006	US7147851 Humanized immunoglobulin reactive with α4β7 integrin
12/12/2006	US7147850 Therapeutic binding agents against MUC-1 antigen and methods for their use
12/12/2006	US7147849 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity
12/12/2006	US7147471 Use of moulding compounds for producing treatment devices
12/12/2006	CA2253809C Molecular genetic construction of vaccine strains of pasteurellaceae
12/12/2006	CA2245425C Neospora vaccine
12/12/2006	CA2201598C Vaccine compositions
12/12/2006	CA2167080C Prrsv recombinant proteins, diagnostic kits and vaccines containing prrs recombinant proteins
12/12/2006	CA2153336C Recombinant virus immunotherapy
12/12/2006	CA2105277C Genetically engineered vaccine strain
12/07/2006	WO2006130834A2 IGGl ANTIBODIES WITH MUTATED FC PORTION FOR INCREASED BINDING TO FCRN RECEPTOR AND USES THEREOF
12/07/2006	WO2006130773A2 Methods of treating brain tumors with antibodies
12/07/2006	WO2006130620A2 Modulation of t cell recruitment
12/07/2006	WO2006130429A2 Treatment of cancer
12/07/2006	WO2006130399A2 Therapeutic combinations and methods including irm compounds
12/07/2006	WO2006130356A2 Non-injection immunotherapy
12/07/2006	WO2006130135A1 Compositions and methods for the treatment of tumor of hematopoietic origin
12/07/2006	WO2006130076A1 Methods for identifying fzd8 modulators and the use of such modulators for treating osteoarthritis
12/07/2006	WO2006130034A1 Method for increasing longevity of a human being and animals
12/07/2006	WO2006130022A1 Modulation of ovulation by agonists and antagonists of bmprii
12/07/2006	WO2006129881A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent
12/07/2006	WO2006129877A1 Novel anti-inflammatory agent
12/07/2006	WO2006129849A1 Anti-cd14 antibody-fused protein
12/07/2006	WO2006129786A1 Methods of diagnosing, preventing and treating infection with hepatitis c virus
12/07/2006	WO2006129729A1 Marker for examination of tolerance of anti-cancer agent for pancreatic cancer, and adjunctive therapeutic agent for anti-cancer agent for pancreatic cancer
12/07/2006	WO2006129658A1 Vaccine and immunization method
12/07/2006	WO2006129162A2 Vaccine compositions and methods for the treatment of urinary incontinence
12/07/2006	WO2006129139A1 N protein mutants of porcine reproductive and respiratory syndrome virus
12/07/2006	WO2006129090A2 Vaccines
12/07/2006	WO2006128715A2 Polyclonal antiserum against a universal tumor antigen
12/07/2006	WO2006128690A1 Anti-il2 antibodies
12/07/2006	WO2006128689A2 Therapeutic composition for use in the prevention and treatment of bone metastases
12/07/2006	WO2006128678A1 Molecular glue
12/07/2006	WO2006128296A1 Pal-based chlamydia vaccine
12/07/2006	WO2006128294A1 Peptide-based influenza vaccine formulation
12/07/2006	WO2006112951A3 Method of risk management for patients undergoing natalizumab treatment
12/07/2006	WO2006102504A3 Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors
12/07/2006	WO2006089141A3 Antibodies against cxcr4 and methods of use thereof
12/07/2006	WO2006083257A3 Drug delivery apparatus utilizing cantilever
12/07/2006	WO2006074399A3 Multispecific binding molecules comprising connecting peptides
12/07/2006	WO2006073422A3 Activation of natural killer (nk) cells and methods of use
12/07/2006	WO2006071989A3 Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
12/07/2006	WO2006063053A3 Methods of producing influenza vaccine compositions
12/07/2006	WO2006045308A3 Chlamydia trachomatis antigens for vaccine and diagnostic use
12/07/2006	WO2006042542A3 Production of tetanus, diphtheria, and pertussis toxins and toxoids using fermentation media containing no components of animal or soy origin
12/07/2006	WO2006006165A3 Use of erythropoietin for enhancing immune responses and for treatment of lymphoproliferative disorders
12/07/2006	WO2005115448A3 Multi plasmid system for the production of influenza virus
12/07/2006	WO2005079848A9 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders
12/07/2006	WO2005048822A3 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
12/07/2006	WO2005044992A3 Fusion initiation region in rna virus envelope proteins
12/07/2006	WO2004074454A3 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
12/07/2006	WO2004024882A3 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
12/07/2006	WO2004003153A3 Live replicating spumavirus vector
12/07/2006	US20060277635 Inducing immunity via oral administration of fusion protein complex comprising (multimeric) cholera toxin and immunogenic antigen
12/07/2006	US20060276633 Method for the mass production of immunoglobulin constant region
12/07/2006	US20060276629 Purification and characterization of soluble human HLA proteins
12/07/2006	US20060276399 Peptide antagonists of zonulin and methods for use of the same
12/07/2006	US20060276396 Stimulating insulin synthesis and release, enhancing adipose, muscle or liver tissue sensitivity towards insulin uptake, stimulating glucose uptake, slowing digestive process, or blocking the secretion of glucagon; glucagon-like protein
12/07/2006	US20060276390 Combined treatments comprising synthetic peptide copolymers for preventing graft rejection
12/07/2006	US20060275897 Plasmid DNA or viral vector vaccine including components from different clades of Env and Gag-Pol-Nef from a single clade; multiclade HIV envelope immunogen
12/07/2006	US20060275845 Diagnosing cancer in humans; obtain sample, detect annexin protein in sample, amplified concentration of annexins indicates cancer
12/07/2006	US20060275796 Canine herpesvirus thymidine kinase nucleic acid molecules
12/07/2006	US20060275783 Gene markers for lung cancer
12/07/2006	US20060275767 Kinase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases and nucleotide sequences encoding such kinase sequences
12/07/2006	US20060275518 Method for treating infectious diseases
12/07/2006	US20060275330 Pygopus in diagnosis and treatment of cancer
12/07/2006	US20060275329 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic
12/07/2006	US20060275328 Instrument for inducing cytokine and method of inducing cytokine
12/07/2006	US20060275327 In vivo modulation of neuronal transport
12/07/2006	US20060275326 Administering a botulinum toxin
12/07/2006	US20060275325 Method for treating allodynia by peripheral administration of a neurotoxin
12/07/2006	US20060275324 Probiotic system for aquaculture
12/07/2006	US20060275323 Particles of HCV envelope proteins: use for vaccination
12/07/2006	US20060275322 producing an immune response to hepatitis C virus infection; activating cytotoxic t lymphocytes in presence of major histocompatibility complex
12/07/2006	US20060275321 Polypeptide antagonists of HIV-1 Tat protein
12/07/2006	US20060275320 Providing a polypeptide having the N-terminal domain of the long form phosphotransacetylase;exposing the polypeptide to a test agent; determining whether the agent binds to the N-terminal domain; binding indicates agent is likely to have virulence-attenuating activity
12/07/2006	US20060275318 Surface protein of leptospira

1 ... 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 ... 1823